Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
Summary
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, April 30, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics Holdings, Inc. (Nasdaq: COAG), a clinical-stage biotechnology co...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.